The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in Acute Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled, Multinational Pivotal Phase III Study

Heart Disease and Stroke Statistics—2010 Update

(2009) et al.   CIRCULATION

The lipophilic zinc chelator DP-b99 prevents zinc induced neuronal death

(2009) Ronit BarKalifa et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review

(2009) Valery L Feigin et al.   LANCET NEUROLOGY

Availability of CT and MR for Assessing Patients with Acute Stroke

(2008) I. Kane et al.   CEREBROVASCULAR DISEASES

Baseline NIH Stroke Scale Responses Estimate the Probability of Each Particular Stroke Subtype

(2008) E.C. Leira et al.   CEREBROVASCULAR DISEASES

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

(2008)   CEREBROVASCULAR DISEASES

Characterizing the Dose-Response Relationship between Mannitol and Intracranial Pressure in Traumatic Brain Injury Patients Using a High-Frequency Physiological Data Collection System

(2008) Marco D. Sorani et al.   JOURNAL OF NEUROTRAUMA

Neuroanatomic correlation of the post-stroke aphasias studied with imaging

(2008) Zhong-Hua Yang et al.   NEUROLOGICAL RESEARCH

A Critique of SAINT II

(2008) Sean I. Savitz et al.   STROKE

National US Estimates of Recombinant Tissue Plasminogen Activator Use

(2008) Dawn Kleindorfer et al.   STROKE

DP-b99, a Membrane-Activated Metal Ion Chelator, as Neuroprotective Therapy in Ischemic Stroke

(2008) Hans-Christoph Diener et al.   STROKE

Time Spent at Home Poststroke

(2007) Terence J. Quinn et al.   STROKE